Wordt geladen...
Perspectives: Other ErbB2-Targeted Therapies
SUMMARY: Despite the success of individualized targeted therapies in women with breast cancer with current available compounds, new drugs – especially with different mechanisms of resistance – are under development. A range of novel targeted agents for women with tumors that overexpress ErbB2 (HER2)...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
S. Karger GmbH
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931098/ https://ncbi.nlm.nih.gov/pubmed/20847930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000285779 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|